PreBid Meeting Roster and Agenda.pdf

This is a PreBid Meeting Roster and Agenda document for the Oregon Health Authority (OHA) and Oregon State Hospital (OSH) drug testing and urinalysis specimen collection services procurement. The RFP (number S-44300-00012831) seeks a qualified contractor to provide comprehensive drug testing services, including 8-panel urinalysis screenings testing for amphetamines, cocaine, morphine/hydrocodone, phencyclidine, MDMA, 6-acetylmorphone, oxycodone/oxymorphone, and marijuana at Junction City and Salem hospital campuses. The contract will span three years initially with potential renewal options extending to five years total. Proposals were due on May 27, 2025, at 3 PM. The procurement evaluation will be comprehensive, totaling 100 possible points across Qualifications (25 points), Drug Testing Services (25 points), Collection Sites and Services (10 points), Laboratory Testing Services (25 points), and Cost (15 points).

The successful contractor must demonstrate appropriate licensing, maintain strict confidentiality protocols, and provide 24/7, 365-day testing services across both campuses with options for expanded testing panels including barbiturates, benzodiazepines, fentanyl, and synthetic cannabinoids. The procurement includes mandatory provisions for disadvantaged business participation, requiring completion of a Certified Disadvantaged Business Outreach Plan addressing opportunities for minority-owned, woman-owned, service-disabled veteran-owned, and emerging small businesses certified by the Oregon Certification Office for Business Inclusion and Diversity (COBID). Additional compliance requirements include non-discrimination attestations, Oregon tax law adherence, wage regulation compliance, exclusion list verification, and completion of a Responsibility Inquiry form demonstrating financial stability and operational capability. Contracts exceeding $500,000 require a Pay Equity Certificate.